HEMOSTASIS COAGULATION RESEARCH ENZYMES KALLIKREIN
Human kallikrein
![](https://www.cryopep.fr/wp-content/uploads/resource/images/pictos/liquide.jpg)
![](https://www.cryopep.fr/wp-content/uploads/resource/images/pictos/RUO.jpg)
![](https://www.cryopep.fr/wp-content/uploads/resource/images/pictos/bioHazard.jpg)
![](https://www.cryopep.fr/wp-content/uploads/resource/images/pictos/stockage_-70C.jpg)
![](https://www.cryopep.fr/wp-content/uploads/resource/images/pictos/importateur.jpg)
![](https://www.cryopep.fr/wp-content/uploads/resource/images/pictos/distributeur.jpg)
Structure : 52 kDa heavy chain and a 33 kDa light chain linked by disulfide bridges.
Formulation : 1mg in a buffer composed of 4mM sodium acetate / hydrochloride, 150mM NaCl, pH 5.3
MW(Da) : 85 000
Coef. Extinction : 1.17
![Click to zoom](https://www.cryopep.fr/wp-content/uploads/resource/generated/thumbnail/Image_11-473_Kallikrein.jpeg)
Reference | 11-473 |
---|---|
Presentation | Vial |
Format | 1 mg |
Quote |
Price list, safety data sheets and notices are accessible to our registered customers.
Reference | Presentation | Format | Quote | Product sheet |
---|---|---|---|---|
11-473 | Vial | 1 mg |